As some other posters have already posted, MNTA’s current valuation entirely or almost entirely discounts a Teva generic entering the market in the near future.
“The efficient-market hypothesis may be the foremost piece of B.S. ever promulgated in any area of human knowledge!”
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.